Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular weekly insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Indian healthcare startup Practo lays off 150 people

Image

08-Apr-17 Indian online doctor discovery and healthcare tech platform Practo has laid off 150 employees following its annual appraisal. The company said “this is a combination of performance and natural redundancies that emerge as we evolve our businesses and integrate our five acquisitions. We continue to rapidly grow our consumer and enterprise businesses and will continue to hire talent across the board”. [image: Times of India]

Read More

Healthcare devices in India registered 150% growth on Amazon

Image

07-Apr-17 According to data from Amazon.in, the healthcare category has grown 150% year on year with some of the top selling products in the category are blood glucose monitors, fitness trackers, and blood pressure monitors. The younger generation are driving these purchases that include for self-use and gifts for parents and grandparents. [image: ET Retail / Amazon]

Read More

Israel's eHealth giant Natali to continue to grow presence in China

Image

06-Apr-17 Natali, Israel's largest private healthcare provider, became a subsidiary of China's Sanpower group in 2014. Since then they have implemented their eHealth/TeleHealth technologies in the Chinese market, amassing 120,000 Israeli subscribers and over 4 mn in China. When asked about the Chinese healthcare market, Nimrod Altman, CEO of Natali Healthcare Group , noted "Barriers are collapsing". [image: PRNewsFoto / Natali Healthcare Group]

Read More

Many American healthtech companies would have more success in emerging markets

Image

06-Apr-17 Global healthcare spending is roughly USD7 tn, according to the US Department of Commerce and many companies would have more success pursuing product approval in emerging markets as the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggested Matthew Hein, representative for the US DoC at the MedTech Intelligence Global Regulatory conference. [image: MedTech Intelligence]

Read More
Share